These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8109910)

  • 1. Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
    Chariot P; Ruet E; Gherardi R
    Ann Neurol; 1994 Feb; 35(2):247-8. PubMed ID: 8109910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Muscular involvement in human immunodeficiency virus infection].
    Laraki R; Lebas J; Baudrimont M; Cabane J; Giral P; Wattiaux MJ; Picard O; Imbert JC
    Ann Med Interne (Paris); 1990; 141(2):187-92. PubMed ID: 2191617
    [No Abstract]   [Full Text] [Related]  

  • 3. Zidovudine-associated myopathy.
    Paradis J; Calis KA
    Am J Hosp Pharm; 1994 Dec; 51(24):3026-8. PubMed ID: 7856620
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].
    Weisser M
    Praxis (Bern 1994); 1997 Oct; 86(43):1708-10. PubMed ID: 9432697
    [No Abstract]   [Full Text] [Related]  

  • 8. [Muscular complications in HIV infection].
    Authier FJ; Chariot P; Gherardi R
    Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
    Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M
    Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peripheral nerve diseases and myopathies associated with HIV infection].
    Nervenarzt; 2000 Jun; 71(6):442-50. PubMed ID: 10919138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 14. Zidovudine-induced leukocytoclastic vasculitis.
    Torres RA; Lin RY; Lee M; Barr MR
    Arch Intern Med; 1992 Apr; 152(4):850-1. PubMed ID: 1558446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
    Till M; MacDonell KB
    Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
    [No Abstract]   [Full Text] [Related]  

  • 16. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myopathies in the course of HIV infection].
    Enting RH; Portegies P; de Visser M
    Ned Tijdschr Geneeskd; 1992 Jul; 136(30):1446-9. PubMed ID: 1331819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Muscular involvement in HIV infection].
    Gherardi R; Chariot P; Authier FJ
    Rev Neurol (Paris); 1995 Nov; 151(11):603-7. PubMed ID: 8745623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia associated with zidovudine therapy.
    Geletko SM; Segarra M; Mikolich DJ
    Pharmacotherapy; 1996; 16(1):79-81. PubMed ID: 8700796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
    Authier FJ; Chariot P; Gherardi RK
    Muscle Nerve; 2005 Sep; 32(3):247-60. PubMed ID: 15902690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.